Adaptive Aerobic Exercise for Alzheimer's Disease
(SMART Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to test 6 months of aerobic exercise in older adults who are 65 years or older and have mild cognitive impairment (MCI) or probable/possible mild Alzheimer's Disease. The main questions it aims to answer are: * test the effects of aerobic exercise on aerobic fitness, white matter hyperintensity (WMH) volume, and patient-centered outcomes; * identify the best exercise to improve aerobic fitness and reduce non-responses over 6 months; and * examines the mechanisms of aerobic exercise's action on memory in older adults with early AD. Participants will receive 6 months of supervised exercise, undergo cognitive data collection and exercise testing 5 times over a year span, have an MRI brain scan 3 times over a one-year span, and have monthly follow-up discussions on health and wellness.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on two or more anti-depression medications or have poorly managed depression or anxiety, you may not be eligible to participate.
What data supports the effectiveness of the treatment Adaptive Aerobic Exercise for Alzheimer's Disease?
Research shows that aerobic exercise can improve physical fitness and mood in Alzheimer's patients, and may enhance cognitive functions like attention and memory. Some studies suggest that combining aerobic exercise with resistance training can lead to significant fitness gains and improve quality of life for those with Alzheimer's disease.12345
Is adaptive aerobic exercise, like HIIT and MICT, safe for humans?
Research shows that both high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) are generally safe for humans, including those with conditions like metabolic syndrome and cardiovascular diseases. These exercises have been studied for their safety and effectiveness in improving fitness and health, with no major safety concerns reported.678910
How does the treatment of aerobic exercise differ from other treatments for Alzheimer's disease?
This treatment is unique because it focuses on improving cardiorespiratory fitness through aerobic exercise, such as High-Intensity Interval Training (HIIT) and Moderate Intensity Continuous Training (MICT), which may help maintain physical fitness and function in Alzheimer's patients. Unlike standard drug treatments, this approach emphasizes physical activity to potentially enhance brain health and fitness.13111213
Research Team
Fang Yu, PhD
Principal Investigator
Arizona State University
Eligibility Criteria
This trial is for adults aged 65 or older with mild cognitive impairment (MCI) or early Alzheimer's Disease. They need medical clearance, a study partner who knows their memory and daily living abilities, and must be living in the community. People can't join if they have certain heart conditions, are on multiple depression medications, do other cognition interventions, exercise heavily already, or have unmanaged anxiety.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 6 months of supervised aerobic exercise, with exercise testing and cognitive data collection occurring 5 times over a year.
Follow-up
Participants have monthly follow-up discussions on health and wellness, and are monitored for safety and effectiveness after treatment.
Extension
Participants may continue with alternative exercise interventions such as HIIT or CARE if identified as non-responders to MICT.
Treatment Details
Interventions
- Chair-based Stretch (Behavioural Intervention)
- Combined Aerobic Resistance Exercise (CARE) (Behavioural Intervention)
- High-Intensity Interval Training (HIIT) (Behavioural Intervention)
- Moderate Intensity Continuous Training (MICT) (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arizona State University
Lead Sponsor
Mark McKenna
Arizona State University
Chief Executive Officer
Bachelor’s degree in marketing from Arizona State University, MBA from Azusa Pacific University
Cedric O’Gorman
Arizona State University
Chief Medical Officer since 2023
MD from Harvard Medical School
Banner Alzheimer's Institute
Collaborator